Background -Bronchial challenge with allergen causes a specific form of airways inflammation consisting of an influx of neutrophils, eosinophils, and T cells. Because the relevance of the challenge model to clinical asthma is uncertain, the cellular changes that occur in the lungs of asthmatic subjects during natural seasonal allergen exposure were investigated. Methods -Seventeen grass pollen sensitive asthmatic subjects with previously reported seasonal exacerbations of asthma kept records of symptoms and underwent fibreoptic bronchoscopy with bronchoalveolar lavage (BAL) and endobronchial biopsy before and during the peak of the grass pollen season. The BAL cells were analysed for differential cell counts and by flow cytometry for T cell subsets and surface activation markers. The biopsy samples were processed into glycol methacrylate resin and immunohistochemical analysis was performed for mast cells, activated eosinophils, T cells and interleukin 4 (IL-4), a cytokine with a pivotal role in allergen-induced inflammation. Results -In the pollen season there was an increase in T lymphocyte activation in the BAL fluid as identified by increased expression of interleukin 2 receptor (IL-2R). In the submucosa these changes were paralleled by an increase in CD4 + T cells. By contrast, the numbers of metachromatic cells in BAL fluid staining with toluidine blue were reduced, possibly because of degranulation following allergen stimulation. In keeping with mast cell activation, the number of mucosal mast cells staining for secreted IL-4 increased during the season. In comparison with the period shortly before the onset of the season, all but two subjects experienced an asthma exacerbation which followed the rise in pollen counts but, compared with the period preceding the first bronchoscopic examination, asthma symptoms were not increased during the pollen season. Conclusions -The data suggest that natural allergen exposure, leading to a clinical exacerbation of asthma, may induce an inflammatory response involving T cells, mast cells and eosinophils. The relationship between allergen exposure, cellular infiltration and activation, and clinical symptoms appears to be complex, with factors other than allergen also contributing to asthmatic activity. (Thorax 1996;51:575-581) 
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Background -Bronchial challenge with allergen causes a specific form of airways inflammation consisting of an influx of neutrophils, eosinophils, and T cells. Because the relevance of the challenge model to clinical asthma is uncertain, the cellular changes that occur in the lungs of asthmatic subjects during natural seasonal allergen exposure were investigated. Methods -Seventeen grass pollen sensitive asthmatic subjects with previously reported seasonal exacerbations of asthma kept records of symptoms and underwent fibreoptic bronchoscopy with bronchoalveolar lavage (BAL) and endobronchial biopsy before and during the peak of the grass pollen season. The BAL cells were analysed for differential cell counts and by flow cytometry for T cell subsets and surface activation markers. The biopsy samples were processed into glycol methacrylate resin and immunohistochemical analysis was performed for mast cells, activated eosinophils, T cells and interleukin 4 (IL-4), a cytokine with a pivotal role in allergen-induced inflammation. Results -In the pollen season there was an increase in T lymphocyte activation in the BAL fluid as identified by increased expression of interleukin 2 receptor (IL-2R). In the submucosa these changes were paralleled by an increase in CD4 + T cells. By contrast, the numbers of metachromatic cells in BAL fluid staining with toluidine blue were reduced, possibly because of degranulation following allergen stimulation. In keeping with mast cell activation, the number of mucosal mast cells staining for secreted IL-4 increased during the season. In comparison with the period shortly before the onset of the season, all but two subjects experienced an asthma exacerbation which followed the rise in pollen counts but, compared with the period preceding the first bronchoscopic examination, asthma symptoms were not increased during the pollen season. Conclusions -The data suggest that natural allergen exposure, leading to a clinical exacerbation of asthma, may induce an inflammatory response involving T cells, mast cells and eosinophils. The relationship between allergen exposure, cellular infiltration and activation, and clinical symptoms appears to be complex, with factors other than allergen also contributing to asthmatic activity. Several studies have used fibreoptic bronchoscopy with bronchoalveolar lavage (BAL) and endobronchial biopsy to demonstrate an influx of inflammatory cells into the airways after allergen challenge consisting of eosinophils'-5 and, to a lesser extent, neutrophils,' 4 monocytes,5 and T lymphocytes.4 It remains, however, unclear how relevant the physiological and pathological observations made under conditions oflaboratory challenge with large quantities of allergen are to the natural course of asthma. Deterioration of asthma seen after allergen challenge is associated with enhanced airways responsiveness lasting days or even weeks, thus mimicking clinical exacerbations of asthma.8'-0 Seasonal changes in airways responsiveness in pollen-sensitive asthmatic subjects" and cellular changes in the nose in patients with seasonal rhinitis, notably increases in eosinophils,'2 suggest that the allergen challenge model may indeed reflect events developing as a consequence of natural inhalation of allergen particles. However, except for one study which showed increased eosinophil counts and mediator levels in BAL fluid in patients with seasonal asthma,'3 convincing pathological evidence linking natural allergen exposure to bronchial mucosal inflammation has been lacking.
To study the course of airways inflammation in relation to a common environmental allergen, a group of grass pollen-sensitive asthmatic subjects with a history of seasonal deterioration of asthma and hay fever were studied. BAL and endobronchial biopsies were performed before and during the season to assess the degree of airways inflammation, as indicated by the extent of infiltration of the bronchi with inflammatory cells and their state of activation. To study the cytokine mechanisms which may explain the inflammatory changes and the seasonal rise in serum IgE levels in atopic subjects sensitive to pollen, the presence of cellular IL-4, a cytokine which is central to IgE production,'4 was determined by immunohistochemistry using specific anti-IL4 monoclonal antibodies. 1' To provide clinical 17) were also sensitive to Dermatophagoides pteronyssinus. In addition, seven subjects were also mildly sensitive to tree pollens. Outside the pollen season, most of the subjects had mild to moderate airways hyperresponsiveness as assessed by low PEF variability (mean 7%, range 1-49%) and the provocative concentration of methacholine causing a 20% fall in forced expiratory volume in one second (PC20), although in two subjects PC20 methacholine was less than 0-1 mg/ml (geometric mean cumulative PC20 1-8 mg/ml, range 0-03-38-1 mg/ml). All were mildly symptomatic but stable before the pollen season, and none were suffering from nocturnal symptoms and morning chest tightness. Ten subjects required salbutamol to relieve asthma symptoms brought on mainly by exercise or cold weather (median usage 0 3 puffs per day, range 0-10). None had been treated with inhaled or oral corticosteroids for several years, and none had suffered from respiratory infections for at least two months before and during the study.
ASSESSMENT OF DISEASE ACTIVITY
Throughout the study the subjects recorded the following asthma symptoms: nocturnal wheeze, nocturnal cough, morning chest tightness, daytime wheeze, and subjective worsening of asthma due to exercise, cold air or fumes. The symptoms were scored on a 0-3 scale (0= absent, 1 = mild, 2 = moderate, 3 =severe) and mean daily scores were calculated. The subjects were also asked to record their salbutamol usage (number of 100,ug puffs per day) and PEF as the best of three pretreatment measurements taken twice daily using a mini-Wright peak flow meter (Airmed, London, UK). PEF variation was calculated as the amplitude % mean (evening minus morning values divided by the mean of the morning plus evening values).
Forced expiratory volume in one second (FEVI) was measured on the day when airways responsiveness was assessed and after refraining from bronchodilator treatment for eight hours. with 3H4 results in a peripheral ring pattern, whereas that with 4D9 results in granular staining. 25 The observation that asthmatic subjects display a mainly peripheral ring staining pattern suggests that 3H4 identifies IL-4 secretion.
To control for non-specific staining we have used subclass matched monoclonal antibody at corresponding titres.
DATA ANALYSIS
Clinical data were analysed in one week periods and expressed as mean weekly values. To document any increase in disease activity associated with pollen exposure baseline data of the week preceding the first bronchoscopic examination were compared with the week before the second bronchoscopic examination, and to document any exacerbations the weeks immediately preceding the pollen season were compared with the peak of the season.
The cell populations in BAL fluid were analysed as absolute numbers per ml BAL fluid derived from their relative numbers counted in cytospins. The CD4+, CD8+, CD25+, and HLA-DR+ cells were shown as a percentage of CD3 + lymphocytes. The cells in the biopsy samples were counted separately in the epithelium and submucosa by a blinded observer and shown as numbers of cells/mm ofbasement membrane and mm2 of submucosa. '7 Differences between logarithmically transformed PC20 methacholine August in all but two subjects which followed, rather than parallelled, the peak of the pollen count (fig 1) . xlnebyplsntsao nmstfou subjects and the complex multifactorial nature of asthma which makes it difficult to conduct ase in submucosal CD4 + studies of the effects of any single provoking of 67 cells/mm2 to 127 factor of asthma. In addition, the total alring the season there was lergenic burden, identified in previous studies ie number of EG2 + eos-to be important in demonstrating a seasonal nucosa in 13 out of 17 effect,'326 was relatively low compared with erence was not significant previous seasons. We assume that the level of exposure to house dust mite during the whole lical staining with both period of the study was constant and are not es for IL-4 showed a me-aware of any studies showing seasonal changes n2 (range 6 2-47.9) stain-in the way this perennial allergen contributes to ibody and 15-5 cells/mm2 mucosal inflammation and asthma symptoms. vith the 4D9 antibody (fig However, triggers such as cold air and pollution before the pollen season. associated with exercise could have contributed g of adjacent sections, all more to the symptoms in the winter than in ined IL-4 also contained spring and summer when pollen exposure in tified them as mast cells, sensitised individuals may be more important. -4 was localised to CD3 + It is therefore possible that the effects of non-)llen season there was a allergenic triggers, which were not controlled twofold increase in the for in the study, may have cancelled differences [ls staining with the 3H4 in symptoms attributable to allergen exposure *7, range 5-1-102-8 cells/ between the two seasons. Nevertheless, the but not in those staining temporal link between the swift increase in the epithelium the median asthma symptoms which followed the rise in ast cells staining with 3H4 pollen counts, associated with decreased ability from 0.1 (0-8-4) to 07 of metachromatic cells to stain with toluidine ange was not significant. blue (suggestive of degranulation) and innce between the epithelial creased expression ofIL-2R (an early activation Ils before and during the marker of T lymphocytes27) support a prompt in 0 (range 0-6-6) versus response to allergenic stimuli.
Our study has also shown that inflammatory cell changes can increase without a parallel change in airways responsiveness that is characteristic of late asthmatic responses. Although ided evidence which sug-airways hyperresponsiveness has been closely osure to grass pollen leads linked to inflammation, it is also apparentthe airways of grass pol-both in animal models28 and in atopic humans29 -that mucosal inflammation may develop without an associated increase in airways responsiveness. The cellular changes in the lower airways which occur during natural allergen exposure were, in some respects, in keeping with those seen in the challenge model. We have found an increase in staining for secreted IL-4 which was localised to mast cells, a finding which suggests mast cell activation. It is now well established that mast cells produce and secrete a variety of cytokines. 25 Immunohistochemical studies of both the upper and lower respiratory mucosae have shown that the number ofmast cells that display a peripheral ring pattern of staining with the 3H9 antibody is increased in atopic asthmatic and rhinitic subjects,'525 suggesting ongoing secretion of preformed IL-4. In this study we provide for the first time in vivo evidence to suggest that exposure to natural allergen results in increased IL-4 secretion by these cells. This could provide possible explanations for some of the observations in this study. Through its capacity to upregulate the vascular cell adhesion molecule 1 (VCAM-1) on endothelial cells, IL-4 is involved in the very late antigen (VLA)-4 dependent recruitment of eosinophils and T cells.3536 The effects of mast cells would be potentiated by activated IL-2R-bearing T cells which would contribute to both numbers and activation of eosinophils and mast cells.37 Although IgE levels rose slightly during the season, the increase did not reach statistical significance, but it is possible that further stimulation with allergen and IL-4 would have resulted in a significant rise in IgE. We have not analysed specific IgE which may have increased, nor have we been able to analyse production of IgE in the lungs which may have taken place without leading to a systemic rise.
In conclusion, we have found changes in the inflammatory cell numbers and activity oflower airways mucosal inflammation associated with exposure to natural allergen. We believe that the observed activation of mast cells, and the activation and recruitment of T cells and possibly eosinophils into the airway wall, may have resulted in the observed cellular changes which in turn could have contributed to the exacerbations of asthma. We have not found a simple relationship between allergen exposure and asthma symptoms in these polysensitised asthmatic subjects during a prolonged period of observation. Finally, in the natural setting the production of proinflammatory cytokines, such as IL-4, and an influx and activation of T cells may precede the accumulation of activated eosinophils in the airways mucosa. 
